Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pancreatic Islet Cell Transplantation After Kidney Transplantation - A Novel Approach to Immunosupression

NCT03047200 is registered in ClinicalTrials.gov with Baylor Research Institute as lead sponsor.

NCT NCT03047200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03047200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pancreatic Islet Cell Transplantation After Kidney Transplantation - A Novel Approach to Immunosupression
Lead sponsor
Baylor Research Institute
Phase
Phase 1
Overall status
Withdrawn
Start date
July 31, 2008
Completion date
January 31, 2017
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

islet cell transplantation, type 1 diabetes